Federated Hermes
GRCL

Federated Hermes’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Federated Hermes’s Portfolio GRCL Stock Details GRCL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$2.42M Hold
2022
Q4 		$2.99M Hold
2022
Q3 		$4.18M Hold
2022
Q2 		$7.14M Hold
2022
Q1 		$3.03M Hold
2021
Q4 		$7.84M Sell
2021
Q3 		$18.1M Buy
2021
Q2 		$15.4M Sell
2021
Q1 		$18.3M Buy